News

Mallinckrodt plc announced that it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K.,…
Read More...

Sanofi announced the appointment of Kathleen Tregoning as member of Executive committee, effective February 27, 2017. Ms. Tregoning will lead Sanofi’s External Affairs organization…
Read More...

uniQure announced that AMT-060,  its proprietary, investigational gene therapy in patients with severe hemophilia B, has received Breakthrough Therapy designation by the U.S. Food and…
Read More...

Mallinckrodt plc, a leading specialty pharmaceutical company, announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690…
Read More...

FDA has granted orphan drug designation for Vicore Pharma's drug candidates C21 for the treatment of IPF. C21 is thereby approved as an orphan drug in the USA. The approval brings C21…
Read More...

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International, and a global drug discovery and development services company providing translational platforms to advance…
Read More...

Medtronic plc (MDT) announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the IN.PACT Admiral…
Read More...

H. Lundbeck is partnering with IBM's Watson Health to sped up the development of new medicines for the treatment of psychiatric and neurological disorders. The collaboration will…
Read More...

Biocon Ltd, Asia's premier biopharmaceuticals company, announced that the Ministry of Health (MoH), Malaysia, has awarded a three year contract, to its subsidiary, Biocon SDN. BHD.,…
Read More...

Five Prime Therapeutics, Inc. announced that the European Commission has granted orphan designation for cabiralizumab (FPA008) for the treatment of tenosynovial giant cell tumour,…
Read More...

uniQure announced the appointment of Alexander Kuta, Ph.D., as Senior Vice President of Regulatory Affairs. Dr. Kuta has more than 25 years of regulatory experience within the industry,…
Read More...

Abzena has entered into a licensing agreement with with a San Diego-based biopharmaceutical firm for its novel site-specific ThioBridge antibody drug conjugate (ADC) linker technology.…
Read More...

Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, announced submission of a new drug application (NDA) for Solosec™…
Read More...

Ethypharm announced that it has signed a definitive agreement to acquire Martindale Pharma. Martindale Pharma is a leading UK-based specialty pharmaceutical company providing…
Read More...

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei…
Read More...

Eli Lilly and Company and CoLucid Pharmaceuticals, Inc. announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million. This all-cash transaction…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc., a privately-held biopharmaceutical company committed to developing medicines that transform the lives of people with…
Read More...

MilliporeSigma announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component…
Read More...

Progenra, Inc. announced a new immune-oncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda. The findings, published by Progenra with Dr. Wayne…
Read More...

Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic…
Read More...